INFLUENCE OF THE AGE OF THE DIAGNOSIS AND THE BEGINNING OF SPECIFIC THERAPY ON MAIN CLINICAL AND LABORATORY MANIFESTATIONS OF A DISEASE IN PATIENTS WITH CYSTIC FIBROSIS
Background: To establish features of a clinical course of a disease at patients depending on age of firstly determine diagnosis of cystic fibrosis. Patients and methods: We examined 130 patients with cystic fibrosis aged under 25 years old. Depending on the age of diagnosis 3 groups of patients were...
Saved in:
| Main Authors: | S. A. Krasovskii, N. Yu. Kashirskaya, M. V. Usacheva, E. L. Amelina, A. V. Chernyak, Zh.K. Naumenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2014-03-01
|
| Series: | Вопросы современной педиатрии |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/205 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013
by: N. Yu. Kashirskaya, et al.
Published: (2015-09-01) -
THE NATIONAL CONSENSUS PROJECT* «CYSTIC FIBROSIS: DEFINITION, DIAGNOSTIC CRITERIA, AND THERAPY». SECTION «INHALATION THERAPY» (ABRIDGED)
by: Ye. L. Amelina, et al.
Published: (2014-12-01) -
DORNASE ALFA IN RUSSIA: 15 YEARS LATER. EFFICACY OF THE DRUG IN THE BASIC TREATMENT IN CHILDREN WITH CYSTIC FIBROSIS
by: O. I. Simonova, et al.
Published: (2012-03-01) -
ROLE OF THE KNOWN MUCOLYTICS IN MUCOVISCIDOSIS THERAPY
by: O. I. Simonova, et al.
Published: (2014-11-01) -
Heterogeneity of phenotypic manifestations of cystic fibrosis in children and predictors of the disease severity
by: K. V. Skriabina, et al.
Published: (2022-12-01)